Bicycle Therapeutics (BCYC) Other Accumulated Expenses (2018 - 2026)

Bicycle Therapeutics has reported Other Accumulated Expenses for 9 years, with the latest figure at $483000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 56.31% year-over-year to $483000.0; the trailing twelve-month figure through Mar 2026 stood at $483000.0 (up 56.31% YoY), and the FY2025 full-year result was $136000.0, down 54.21% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $483000.0, up from $136000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $1.5 million in Q4 2022, with the low at $136000.0 in Q4 2025.
• Historically, Other Accumulated Expenses has averaged $504529.4 across 5 years, with a median of $384000.0 in 2022.
• Annual changes were most pronounced in 2022 — Other Accumulated Expenses soared 1396.88% — and 2023, when it slumped 82.54%.
• Bicycle Therapeutics' Other Accumulated Expenses stood at $1.5 million in 2022, then slumped by 82.54% to $257000.0 in 2023, then rose by 15.56% to $297000.0 in 2024, then sank by 54.21% to $136000.0 in 2025, then surged by 255.15% to $483000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $483000.0 (Q1 2026), $136000.0 (Q4 2025), and $204000.0 (Q3 2025), per Business Quant data.